This announcement is a separate document:
康龙化成：上海信公轶禾企业管理咨询有限公司关于康龙化成（北京）新药技术股份有限公司2021年A股限制性股票激励计划第三个归属期归属条件成就相关事项之独立财务顾问报告
Kanglong Chemical: Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on matters relating to the achievement of ownership conditions during the third vesting period of Kanglong Chemical (Beijing) New Pharmaceutical Technology Co., Ltd. 2021 A-share Restricted Stock Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated